Ambuja Cements Ltd (AMBUJACEM)
π― Key Takeaways
- Revenue declined 13% QoQ to βΉ9,500 in Q1FY27.
- Market Cap
- βΉ91,193
- P/E Ratio
- 20.6
- P/B Ratio
- 1.54
- ROE
- 7.4%
- ROCE
- 4.9%
- Debt/Equity
- 0.00
- Div Yield
- 0.54%
- Promoter
- 67.3%
π Quarterly Results (βΉ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 9,174 | 10,277 | 10,916 | 9,500 |
| Operating Profit | 876 | 442 | 412 | 755 |
| OPM % | 9.6% | 4.3% | 3.8% | 8.0% |
| Net Profit | 2,302 | 403 | 1,857 | 660 |
| EPS | βΉ7.15 | βΉ0.97 | βΉ7.41 | βΉ2.32 |
π¦ Balance Sheet (βΉ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 493 | 493 | 494 | 494 |
| Reserves | 53,086 | 49,883 | 58,850 | 55,752 |
| Borrowings | 789 | 779 | 53 | 1,271 |
| Total Liabilities | 81,106 | 76,572 | 89,607 | 88,710 |
| Fixed Assets | 26,514 | 24,101 | 58,299 | 33,526 |
| Investments | 1,912 | 2,223 | 113 | 104 |
| Total Assets | 81,106 | 76,572 | 89,607 | 88,710 |
π° Cash Flow Statement (βΉ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +5,362 |
| Investing | -7,935 |
| Financing | -1,629 |
| Net Cash Flow | -4,203 |
π₯ Shareholding Pattern
| Category | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|
| Promoters | 67.7% | 67.7% | 67.3% |
| FII | 5.8% | 5.9% | 5.6% |
| DII | 19.9% | 20.1% | 19.7% |
| Public | 5.0% | 4.9% | 5.5% |
| # Shareholders | 6,25,013 | 6,07,505 | 6,74,206 |
βοΈ Peer Comparison β Cement
| Company | MCap (βΉ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| ULTRACEMCO | 3.20 L Cr | 37.4 | 13.4% | β | 0.30 |
| AMBUJACEM | 91,193 | 20.6 | 4.9% | β | 0.00 |
| SHREECEM | 78,630 | 48.2 | 9.6% | β | 0.07 |
| JKCEMENT | 37,306 | 39.5 | 13.7% | β | 0.86 |
| DALBHARAT | 30,856 | 33.0 | 6.9% | β | 0.38 |
| ACC | 22,620 | 11.8 | 9.3% | β | 0.00 |
| RAMCOCEM | 19,910 | 30.9 | 10.1% | β | 0.48 |
| JSWCEMENT | 15,351 | 19.6 | 10.2% | β | 0.62 |
| NUVOCO | 11,793 | 30.6 | 7.6% | β | 0.42 |
| INDIACEM | 9,438 | 102.2 | 1.8% | β | 0.13 |
π Peer Stock Analyses
π Recent Filings
- π‘ voting results2026-09-30Ambuja Cements shareholders approved the ACC merger scheme via overwhelming remote e-voting, with 99.98% in favor and only 0.02% against, following a β¦
- π΄ Announcement2026-09-30Ambuja Cements announced the commissioning of two new production units that add 5.4 million tonnes per annum of capacity, raising its consolidated capβ¦
- π‘ voting results2026-09-30Ambuja Cements shareholders approved the ACC merger scheme via remote e-voting and meeting, with 99.98% voting in favor. The resolution passed with ovβ¦
- π‘ voting results2026-09-29Ambuja Cements shareholders approved the Scheme of Amalgamation with ACC Limited at a court-convened meeting on September 29, 2026, with the resolutioβ¦
- π‘ voting results2026-09-29Ambuja Cements shareholders approved the Scheme of Amalgamation with ACC Limited at a September 29, 2026 meeting convened under NCLT order. The resoluβ¦
- π‘ voting results2026-09-28Ambuja Cements shareholders approved the Scheme of Amalgamation with Orient Cement at a September 28, 2026 meeting convened under NCLT order, achievinβ¦
- Announcement2026-09-28Ambuja Cements announced that its trading window will close on October 1, 2026, for 48 hours after the unaudited financial results for the quarter andβ¦
- π‘ voting results2026-09-28
- π΄ Announcement2026-09-21Ambuja Cements announced an investor and analyst interaction scheduled for September 25, 2026, in Ahmedabad, providing a platform for market participaβ¦
- π΄ Announcement2026-09-16Ambuja Cements announced an investor and analyst interaction schedule on September 21 and 22, 2026, in Mumbai and via virtual platforms, to discuss puβ¦
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights β sign up free to unlock.
Sign Up Free β Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only β not investment advice. Updated 2026-10-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
π‘ Get AI alerts when AMBUJACEM files new disclosures
Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track AMBUJACEM β FreeFree account Β· 2 AI queries/day